Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25FMQNA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $4,311
Award facts
- Contract value 100% obligated
- $4,311.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4566736518 XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product.
This delivery order contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The delivery order has an ultimate completion date of December 17, 2024.
This contract award does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal contracts across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA and other Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DX25FMQNA?
SPE2DX25FMQNA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on December 16, 2024.
How much is contract SPE2DX25FMQNA worth?
The government has obligated $4,311 on SPE2DX25FMQNA.
Is contract SPE2DX25FMQNA an order under another contract?
Yes. SPE2DX25FMQNA is a delivery order under SPE2DX15D9320, an indefinite delivery contract.
Was contract SPE2DX25FMQNA competed?
The extent of competition for SPE2DX25FMQNA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award